Market Recap Check: Alignment Healthcare Inc (ALHC)’s Negative Finish at 13.46, Up/Down -1.54

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Alignment Healthcare Inc (NASDAQ: ALHC) closed at $13.46 in the last session, down -1.54% from day before closing price of $13.67. In other words, the price has decreased by -$1.54 from its previous closing price. On the day, 1.25 million shares were traded. ALHC stock price reached its highest trading level at $13.8995 during the session, while it also had its lowest trading level at $13.25.

Ratios:

We take a closer look at ALHC’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 1.92 whereas as Long-Term Debt/Eq ratio is at 1.91.

On May 30, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $7.75 to $11.

On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $10.Robert W. Baird initiated its Outperform rating on May 30, 2024, with a $10 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 04 ’24 when Kardes Hakan sold 20,500 shares for $13.06 per share. The transaction valued at 267,699 led to the insider holds 355,444 shares of the business.

Kardes Hakan sold 4,500 shares of ALHC for $58,413 on Nov 01 ’24. The Chief Experience Officer now owns 375,944 shares after completing the transaction at $12.98 per share. On Nov 01 ’24, another insider, HAKAN KARDES, who serves as the Officer of the company, bought 25,000 shares for $12.40 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2580228096 and an Enterprise Value of 2420520448. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.04 while its Price-to-Book (P/B) ratio in mrq is 22.51. Its current Enterprise Value per Revenue stands at 0.981 whereas that against EBITDA is -25.838.

Stock Price History:

Over the past 52 weeks, ALHC has reached a high of $14.25, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 18.45%, while the 200-Day Moving Average is calculated to be 66.36%.

Shares Statistics:

According to the various share statistics, ALHC traded on average about 1.28M shares per day over the past 3-months and 1667010 shares per day over the past 10 days. A total of 188.95M shares are outstanding, with a floating share count of 87.18M. Insiders hold about 54.52% of the company’s shares, while institutions hold 40.95% stake in the company. Shares short for ALHC as of 1728950400 were 4422127 with a Short Ratio of 3.46, compared to 1726185600 on 4752562. Therefore, it implies a Short% of Shares Outstanding of 4422127 and a Short% of Float of 3.61.

Most Popular